
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1015 | 970 | 1056 | 1058 | 1589 | - |
Fund Return | 1.47% | -3.03% | 5.56% | 1.88% | 9.71% | - |
Place in category | 50 | 11 | 278 | 367 | 228 | - |
% in Category | 11 | 4 | 57 | 79 | 55 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 22.6B | 6.17 | 10.21 | 7.91 | ||
Artisan International Value Advisor | 11.12B | 6.13 | 10.11 | - | ||
Artisan Mid Cap Institutional | 4.01B | 1.51 | 1.98 | 9.53 | ||
Artisan Mid Cap Investor | 4.01B | 1.47 | 1.76 | 9.28 | ||
Artisan International Small Cap Ins | 3.11B | 1.49 | -0.40 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.28B | 3.95 | 11.91 | 12.12 | ||
Vanguard Mid-Cap Growth Index Admir | 12.89B | 2.32 | 6.64 | 10.11 | ||
T. Rowe Price Mid-Cap Growth I | 11.72B | -1.57 | 4.66 | - | ||
T. Rowe Price Mid-Cap Growth | 10.77B | -1.59 | 4.52 | 9.48 | ||
T. Rowe Price New Horizons I | 8.43B | -2.44 | -2.12 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 4.97 | 605.52 | -0.40% | |
Spotify Tech | LU1778762911 | 4.20 | 615.70 | +1.82% | |
West Pharmaceutical Services | US9553061055 | 3.84 | 225.80 | -2.63% | |
Tyler Technologies | US9022521051 | 3.64 | 580.30 | +1.03% | |
Ascendis Pharma AS | US04351P1012 | 3.22 | 161.04 | -4.14% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell |
Technical Indicators | Strong Buy | Strong Sell | Sell |
Summary | Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review